21.17
4.23%
0.86
Vorhandelsmarkt:
26.79
5.62
+26.55%
Finanzdaten der Anaptysbio Inc-Aktie (ANAB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
20.28%
7.179
|
9.005 | 3.318 | 3.46 | 1.374 |
Operating Expenses
|
3.44%
49.38
|
51.14 | 41.05 | 43.60 | 45.77 |
Benefits Costs and Expenses |
100.00%
-
|
180.78 | - | - | - |
Costs And Expenses |
1.93%
49.38
|
50.35 | 41.05 | 43.60 | 45.77 |
Operating Income/Loss |
0.16%
-42.20
|
-42.13 | -37.73 | -40.14 | -44.40 |
Nonoperating Income/Loss |
2,069%
-1.735
|
-0.08 | 0.424 | 0.298 | 0.146 |
Income/Loss From Continuing Operations Before Tax |
104.18%
7.179
|
-171.78 | 3.318 | -39.84 | -44.26 |
Income/Loss From Continuing Operations After Tax |
4.09%
-43.94
|
-42.21 | -37.31 | -39.84 | -44.26 |
Net Income/Loss
|
4.09%
-43.94
|
-42.21 | -37.31 | -39.84 | -44.26 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
23,610%
26.80
|
-0.114 | 26.55 | 26.63 | 27.95 |
Diluted Average Shares |
23,610%
26.80
|
-0.114 | 26.55 | 26.63 | 27.95 |
Basic Earnings Per Share |
3.14%
-1.64
|
-1.59 | -1.41 | -1.50 | -1.58 |
Diluted Earnings Per Share |
3.14%
-1.64
|
-1.59 | -1.41 | -1.50 | -1.58 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):